Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $99.56 USD
Change Today -0.80 / -0.80%
Volume 984.2K
NVS On Other Exchanges
Symbol
Exchange
Xetra
New York
OTC US
Mexico
SIX Swiss Ex
SIX Swiss Ex
Frankfurt
As of 6:40 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - novartis ag-sponsored adr (NVS)

NameBoard RelationshipsTitleAge
Joseph Jimenez MBA7 RelationshipsChief Executive Officer54
Harry Kirsch 13 RelationshipsChief Financial Officer48
Mark C. Fishman M.D.No RelationshipsPresident of Institutes for Biomedical Research (NIBR)63
Bruno Strigini No RelationshipsPresident of Novartis Oncology--
André Wyss No RelationshipsGlobal Head of Novartis Business Services and Country President of Switzerland46

Board Members - novartis ag-sponsored adr (NVS)

NameBoard RelationshipsPrimary CompanyAge
Joerg Reinhardt Ph.D.12 RelationshipsNovartis Consumer Health, Inc.58
Enrico Vanni Ph.D.36 RelationshipsNovartis AG63
Alex Krauer Ph.D.22 RelationshipsNovartis AG--
Daniel L. Vasella M.D.121 RelationshipsNovartis AG61
Pierre Landolt Ph.D.27 RelationshipsSandoz Family Foundation, Endowment Arm67

Executive Committees* - novartis ag-sponsored adr (NVS)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeSrikant Madhav Datar Ph.D. 54 Relationships4 Executives
Compensation CommitteeEnrico Vanni Ph.D. 36 Relationships3 Executives
Nominating CommitteePierre Landolt Ph.D. 27 Relationships2 Executives
Corporate Governance CommitteePierre Landolt Ph.D. 27 Relationships2 Executives
View NVS Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $99.56 USD -0.80

NVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $101.08 USD +1.22
Johnson & Johnson $100.14 USD -0.20
Merck & Co Inc $57.60 USD -0.66
Pfizer Inc $34.16 USD -0.14
Roche Holding AG SFr.263.90 CHF -4.90
View Industry Companies
 

Industry Analysis

NVS

Industry Average

Valuation NVS Industry Range
Price/Earnings 23.4x
Price/Sales 4.5x
Price/Book 3.4x
Price/Cash Flow 26.7x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-SPONSORED ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.